Home / World / Archive by category Survey and Research (Page 2)

Archive by category Survey and Research

Junshi Biosciences Announces UK MHRA Approval for Marketing of Toripalimab

SHANGHAI, Nov. 16, 2024 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, and its wholly-owned subsidiary, TopAlliance Biosciences Inc. (TopAlliance Biosciences), announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved [...]

Curium Announces ECLIPSE Trial Has Met Primary Endpoint, Demonstrating a Statistically Significant and Clinically Meaningful Benefit for Patients With PSMA-Positive Metastatic Castration Resistant Prostate Cancer

ST. LOUIS, Nov. 13, 2024 (Korea Bizwire) – Curium, a world leader in nuclear medicine, announced today that its ECLIPSE trial met its primary endpoint. ECLIPSE is a pivotal Phase 3, multi-center, open-label, randomized clinical trial comparing the safety and efficacy of 177Lu-PSMA-I&T (INN: lutetium (177Lu) zadavotide guraxetan) versus hormone therapy in patients with metastatic castration-resistant [...]

EAACI to Launch World Anaphylaxis Awareness Day on 21 November at FAAM-EUROBAT 2024

ATHENS, Greece, Nov. 13, 2024 (Korea Bizwire) – The European Academy of Allergy and Clinical Immunology (EAACI) is proud to announce the inaugural World Anaphylaxis Awareness Day on 21 November 2024. This landmark initiative, held on the opening day of FAAM-EUROBAT 2024 in Athens, Greece, seeks to raise awareness and promote essential steps in preventing and managing anaphylaxis, a severe, [...]

Timor-Leste eliminates lymphatic filariasis as a public health problem

DECATUR, Ga., Nov. 12, 2024 (Korea Bizwire) – The Mectizan Donation Program applauds Timor-Leste for eliminating lymphatic filariasis (LF) as a public health problem, a remarkable achievement that was recently validated by the World Health Organization (WHO). Timor-Leste is the fifth country in Southeast Asia to achieve this milestone and the first country in the region [...]

Clean Core Achieves Historic Burnup Milestone with its Thorium Fuel at US National Lab

First-of-its-kind, thorium-based ANEEL™ fuel moves a step closer to commercialization CHICAGO, Nov. 12, 2024 (Korea Bizwire) – Clean Core Thorium Energy (Clean Core) announced that its patented ANEEL™ fuel (Advanced Nuclear Energy for Enriched Life) has reached a groundbreaking burnup milestone in the Advanced Test Reactor (ATR) at Idaho National Laboratory (INL). This achievement represents [...]

AI Integration in SMBs: Balancing Fear and FOMO

Builder.ai Survey Highlights SMBs Push Toward a Digital Future Amid Challenges LONDON, Nov. 12, 2024 (Korea Bizwire) – Artificial Intelligence (AI) is transforming industries, with small and medium sized businesses (SMBs) feeling the pressure. Builder.ai, the AI-powered composable software platform that allows every business to become digitally powered, today announces that they surveyed SMBs in [...]

Boehringer Ingelheim and the Mary Tyler Moore Vision Initiative join forces to combat vision loss from diabetes

·More than 530 million people worldwide living with diabetes are at risk for developing diabetic retinal disease (DRD), the leading cause of blindness in working-age adults. 1 ·DRD is a growing epidemic that is expected to increase as the incidence of diabetes escalates across the globe.2,3 ·There is an urgent need for earlier detection of DRD [...]

OPEN Health Presents First Collection of Research Backed by Scientific Buyout Fund to Foster Research and Development

London, Nov. 11, 2024 (Korea Bizwire) – OPEN Health, a preeminent global provider of scientific communications, HEOR and market access, patient engagement, and consulting services, today announced the upcoming presentation of a collection of research supported by its Scientific Buyout Program. The Scientific Buyout Program initiative allows staff members to “buy out” time from their regular duties to engage in important scientific [...]

Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infiltrating T-cells, and effective tumor growth inhibition in murine models of breast, colorectal, and prostate cancers

SPRING, Texas, Nov. 08, 2024 (Korea Bizwire) – Io Therapeutics, Inc., presented results from studies done in breast, colorectal, and prostate cancer models with the company’s newest anti-cancer compound IRX5010, an agonist of the retinoic acid nuclear receptor gamma, which was discovered in the company’s oncology drug program. The presentation titled “RAR Gamma Agonist Compounds [...]

Bitget Protection Fund Hits $424 Million Average, a 40% Increase from its Initial Commitment

VICTORIA, Seychelles, Nov. 08, 2024 (Korea Bizwire) – Bitget, the leading cryptocurrency exchange and Web3 company, has released the latest valuation of its Protection Fund for October 2024. The fund, an essential safeguard for the exchange indicates the platform’s ongoing measures to secure user assets and uphold financial stability. Throughout October, the Protection Fund experienced notable [...]